Skip to main content

Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.

Publication ,  Journal Article
Kumar, A; Nalawade, V; Riviere, P; Sarkar, RR; Parsons, JK; Murphy, JD; Rose, BS
Published in: JAMA network open
October 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA network open

DOI

EISSN

2574-3805

ISSN

2574-3805

Publication Date

October 2019

Volume

2

Issue

10

Start / End Page

e1913612

Related Subject Headings

  • United States
  • SEER Program
  • Prostatic Neoplasms
  • Prostatic Hyperplasia
  • Prostate-Specific Antigen
  • Neoplasm Staging
  • Neoplasm Grading
  • Medicare
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kumar, A., Nalawade, V., Riviere, P., Sarkar, R. R., Parsons, J. K., Murphy, J. D., & Rose, B. S. (2019). Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. JAMA Network Open, 2(10), e1913612. https://doi.org/10.1001/jamanetworkopen.2019.13612
Kumar, Abhishek, Vinit Nalawade, Paul Riviere, Reith R. Sarkar, J Kellog Parsons, James D. Murphy, and Brent S. Rose. “Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.JAMA Network Open 2, no. 10 (October 2019): e1913612. https://doi.org/10.1001/jamanetworkopen.2019.13612.
Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, et al. Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. JAMA network open. 2019 Oct;2(10):e1913612.
Kumar, Abhishek, et al. “Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.JAMA Network Open, vol. 2, no. 10, Oct. 2019, p. e1913612. Epmc, doi:10.1001/jamanetworkopen.2019.13612.
Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, Rose BS. Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. JAMA network open. 2019 Oct;2(10):e1913612.

Published In

JAMA network open

DOI

EISSN

2574-3805

ISSN

2574-3805

Publication Date

October 2019

Volume

2

Issue

10

Start / End Page

e1913612

Related Subject Headings

  • United States
  • SEER Program
  • Prostatic Neoplasms
  • Prostatic Hyperplasia
  • Prostate-Specific Antigen
  • Neoplasm Staging
  • Neoplasm Grading
  • Medicare
  • Male
  • Humans